Phase I Trial of Pomalidomide for Patients With Relapsed/Refractory Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 18 Jul 2019 Status changed from active, no longer recruiting to completed.
- 27 Sep 2018 Results published in the Blood
- 17 Sep 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.